AIDX

0.157113.01%
PR

Prasanth Reddy

Independent Director

Dr. Prasanth Reddy, M.D., M.P.H. & FACP, is an Independent Director of 20/20 Biolabs, Inc. since November 2023. He serves as Chief Medical Officer of Mercy BioAnalytics, Inc. since July 2025. He is Independent Director of GeneCentric Therapeutics, Inc. from November 2023. He served as Senior Vice President and Head of Enterprise Oncology at Laboratory Corporation of America Holdings since February 2021. Dr. Reddy was vice president of medical affairs at Foundation Medicine, Inc. (FMI). He is triple board-certified in internal medicine, medical oncology and hematology and he practiced medicine and served in leadership positions for more than a decade in various clinical settings including academia, private practice and managed care. Prior to FMI, Dr. Reddy worked as a national leader developing oncology service line treatment pathways at the Adventist Health System. Dr. Reddy is Director of LynkCare, Inc. from 2025. Dr. Reddy also serves as a Lieutenant Colonel in the U.S. Air Force Reserve, with nearly two decades of service to his country. Dr. Reddy earned a bachelor’s degree in microbiology and psychology from Kansas State University and he earned his medical degree from the University of Kansas Medical Center, where he also completed his internal medicine residency and clinical hematology and oncology fellowship. Dr. Reddy obtained a master’s degree in public health through a National Institutes of Health Clinical Research Curriculum Award (K30) and is an alumnus of Harvard Business School. Additionally, he is a fellow of the American College of Physicians and is a Certified Physician Executive.

Positions